A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

NCT00309725 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: galantamine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.